Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin.
Chen X, Xu Y, Zhang J, Shao S, Duan Y, Liu P, Shen L, Zhang J, Zeng J, Lin M, Zhao S, Ma J, Zhao T, Hu J, Liao Y, Chen X, Hu S, Xue Y, Zeng Z, He W, Liu Z, Li W, Liu L, Yin P, Yu X.
Chen X, et al. Among authors: yu x.
Endocr Pract. 2021 Aug;27(8):790-797. doi: 10.1016/j.eprac.2021.03.015. Epub 2021 Apr 6.
Endocr Pract. 2021.
PMID: 33831552
Clinical Trial.